Developmental CellMolecular BiologyPeer-reviewed journal article
BCKDK regulates the TCA cycle through PDC to ensure embryonic development in the absence of PDK family
Lia Heinemann‐YerushalmiiD, Lital Bentovim, Neta FelsenthaliD, Ron Carmel VinestockiD, Nofar Michaeli, Sharon Krief, Alon Silberman, Marina Cohen, Shifra Ben‐DoriD, Ori Jacob BrenneriD, Rebecca Haffner‐KrausziD, Maxim ItkiniD, Sergey MalitskyiD, Ayelet EreziD, Elazar ZelzeriD
Abstract
Pyruvate dehydrogenase kinases (PDK1-4) inhibit the TCA cycle by phosphorylating pyruvate dehydrogenase complex (PDC). Here, we show that the PDK family is dispensable for the survival of murine embryonic development and that BCKDK serves as a compensatory mechanism by inactivating PDC. First, we knocked out all four Pdk genes one by one. Surprisingly, Pdk total KO embryos developed and were born in expected ratios, but died by postnatal day 4 due to hypoglycemia or ketoacidosis. Finding that PDC was phosphorylated in these embryos suggested that another kinase compensates for the PDK family. Bioinformatic analysis implicated brunch chain ketoacid dehydrogenase kinase (Bckdk), a key regulator of branched chain amino acids (BCAA) catabolism. Indeed, knockout of Bckdk and the Pdk family led to loss of PDC phosphorylation, increment in PDC activity, elevation of Pyruvate flux into the TCA and early embryonic lethality. These findings reveal a new regulatory crosstalk hardwiring BCAA and glucose catabolic pathways, which feed the TCA cycle.
- Citations
- 27
- FWCI
- 1.75
- Field percentile
- top 17%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pyruvate dehydrogenase kinase 1 controls triacylglycerol hydrolysis in cardiomyocytes
Michael G. Atser, Chelsea D. Wenyonu, … James D. Johnson·Journal of Biological ChemistryPeer-reviewed·Mar 10, 2025
- Upregulation of the AMPK-FOXO1-PDK4 pathway is a primary mechanism of pyruvate dehydrogenase activity reduction and leads to increased glucose uptake in tafazzin-deficient cells
Zhuqing Liang, Tyler Ralph-Epps, … Miriam L. Greenberg·bioRxiv·Feb 3, 2024
- Opposing effects of systemic and pancreas-specific inhibition of BCKDK on pancreatic carcinogenesis
Michael Noji, Christina Demetriadou, … Kathryn E. Wellen·bioRxiv·Jun 10, 2025
- Partial suppression of BCAA catabolism as a potential therapy for BCKDK deficiency
Laura Ohl, Amanda Kuhs, … Rebecca C. Ahrens‐Nicklas·Molecular Genetics and Metabolism ReportsPeer-reviewed·May 10, 2024
- Cardiomyocyte pyruvate dehydrogenase kinase 1 knockout activates Rho-mediated remodeling and decreases fatty acyl availability in female mice
Michael G. Atser, Sareh Panahi, … James D. Johnson·bioRxiv·Jul 31, 2026
- Silencing branched-chain ketoacid dehydrogenase or treatment with branched-chain ketoacids ex vivo inhibits muscle insulin signaling
D. Biswas, K. T. Dao, … T. Pulinilkunnil·bioRxiv·Feb 21, 2020